Australia markets close in 1 hour 3 minutes

Evoke Pharma, Inc. (EVOK)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.0300+0.5500 (+37.16%)
At close: 04:00PM EST
1.9698 -0.06 (-2.97%)
After hours: 07:53PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
2,073
1,618
23.02
0
0
Cost of revenue
316.989
328.118
86.712
-
-
Gross profit
1,756
1,290
-63.692
-
-
Operating expenses
Research development
309.305
590.476
6,555
3,416
4,095
Selling general and administrative
9,070
8,851
6,429
3,738
3,920
Total operating expenses
9,380
9,442
12,984
7,154
8,015
Operating income or loss
-7,624
-8,152
-13,047
-7,154
-8,015
Interest expense
499.999
500.05
112.994
-
-
Total other income/expenses net
-
105.13
-
-
433.392
Income before tax
-8,093
-8,538
-13,155
-7,126
-7,566
Income from continuing operations
-8,093
-8,538
-13,155
-7,126
-7,566
Net income
-8,093
-8,538
-13,155
-7,126
-7,566
Net income available to common shareholders
-8,093
-8,538
-13,155
-7,126
-7,566
Basic EPS
-
-3.24
-6.24
-3.84
-5.52
Diluted EPS
-
-3.24
-6.24
-3.84
-5.52
Basic average shares
-
2,682
2,124
1,858
1,384
Diluted average shares
-
2,682
2,124
1,858
1,384
EBITDA
-
-8,038
-13,042
-7,154
-8,015